Maximilian is a Research Officer within LSE Health and CPEC and a part-time PhD student in the Department of Health Policy at LSE. His research interests include pharmaceutical regulation and policy, evidence synthesis, comparative effectiveness research, decision-making at the patient and population levels, and economic evaluation.
Maximilian’s PhD research focuses on evidence requirements for drug marketing authorisation. His empirical work includes an evaluation of evidence standards in expedited approval pathways, focusing on uncertainty and the role of non-randomised studies for regulatory decision-making. He holds an MSc in Health Policy, Planning and Financing from LSE and the London School of Hygiene and Tropical Medicine and a BSc in Business, Economics and Social Sciences from the Vienna University of Economics and Business (WU).